Yoshiyuki Watanabe, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Venae Cavae | 1 | 2016 | 41 | 0.560 |
Why?
|
| Heart Atria | 1 | 2016 | 1361 | 0.350 |
Why?
|
| Antigens, CD1 | 2 | 2006 | 434 | 0.260 |
Why?
|
| BCG Vaccine | 1 | 2006 | 383 | 0.210 |
Why?
|
| Catheter Ablation | 1 | 2016 | 2775 | 0.210 |
Why?
|
| Adipogenesis | 2 | 2022 | 370 | 0.210 |
Why?
|
| Follistatin | 1 | 2022 | 138 | 0.190 |
Why?
|
| Antibodies, Bacterial | 1 | 2006 | 1481 | 0.170 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2019 | 93 | 0.160 |
Why?
|
| Adipose Tissue, White | 1 | 2021 | 371 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2019 | 419 | 0.150 |
Why?
|
| Immunoglobulins | 1 | 2021 | 856 | 0.150 |
Why?
|
| Lipids | 1 | 2006 | 3346 | 0.120 |
Why?
|
| Mice, Transgenic | 3 | 2022 | 9558 | 0.120 |
Why?
|
| Adipocytes | 1 | 2021 | 1199 | 0.120 |
Why?
|
| Antioxidants | 1 | 2021 | 1678 | 0.110 |
Why?
|
| Tuberculosis | 1 | 2006 | 2030 | 0.110 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2021 | 1816 | 0.100 |
Why?
|
| Gene Deletion | 1 | 2019 | 2674 | 0.100 |
Why?
|
| Myocardial Contraction | 1 | 2016 | 1527 | 0.090 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2021 | 1671 | 0.090 |
Why?
|
| Models, Animal | 1 | 2016 | 2126 | 0.090 |
Why?
|
| Adipose Tissue | 1 | 2021 | 3335 | 0.080 |
Why?
|
| Dietary Supplements | 1 | 2021 | 3445 | 0.080 |
Why?
|
| T-Lymphocytes | 1 | 2006 | 10273 | 0.080 |
Why?
|
| Swine | 1 | 2016 | 5996 | 0.070 |
Why?
|
| Guinea Pigs | 1 | 2006 | 1310 | 0.060 |
Why?
|
| Bacteroidetes | 1 | 2023 | 85 | 0.050 |
Why?
|
| Mycobacterium bovis | 1 | 2003 | 148 | 0.050 |
Why?
|
| Xanthophylls | 1 | 2021 | 95 | 0.050 |
Why?
|
| Mice, Congenic | 1 | 2021 | 98 | 0.050 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2016 | 3682 | 0.050 |
Why?
|
| Animals | 6 | 2022 | 169418 | 0.040 |
Why?
|
| Japan | 2 | 2019 | 1418 | 0.040 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2006 | 1797 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2006 | 2216 | 0.040 |
Why?
|
| Influenza Vaccines | 1 | 2005 | 781 | 0.040 |
Why?
|
| Muscles | 1 | 2022 | 1582 | 0.040 |
Why?
|
| Macrophages | 2 | 2022 | 5797 | 0.040 |
Why?
|
| Gastrointestinal Tract | 1 | 2023 | 840 | 0.030 |
Why?
|
| Magnesium | 1 | 2019 | 816 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2019 | 12242 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2006 | 5495 | 0.030 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2006 | 1931 | 0.030 |
Why?
|
| Mice | 4 | 2022 | 82045 | 0.030 |
Why?
|
| Influenza, Human | 1 | 2005 | 1540 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2006 | 4572 | 0.030 |
Why?
|
| Vaccination | 1 | 2005 | 3434 | 0.030 |
Why?
|
| Syndrome | 1 | 2019 | 3278 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2021 | 1892 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 22365 | 0.030 |
Why?
|
| Pancreas | 1 | 2019 | 1703 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2021 | 2575 | 0.020 |
Why?
|
| Bacteria | 1 | 2023 | 2226 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2021 | 3145 | 0.020 |
Why?
|
| Glucose | 1 | 2021 | 4355 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2003 | 4642 | 0.020 |
Why?
|
| Mitochondria | 1 | 2021 | 3672 | 0.020 |
Why?
|
| Gene Expression | 1 | 2021 | 7605 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2021 | 3974 | 0.020 |
Why?
|
| Cytokines | 1 | 2021 | 7449 | 0.020 |
Why?
|
| Calcium | 1 | 2019 | 5793 | 0.020 |
Why?
|
| Liver | 1 | 2019 | 7575 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2021 | 11674 | 0.010 |
Why?
|
| Antibodies, Blocking | 1 | 2003 | 250 | 0.010 |
Why?
|
| Inflammation | 1 | 2021 | 10865 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2003 | 743 | 0.010 |
Why?
|
| Male | 5 | 2021 | 364781 | 0.010 |
Why?
|
| Antigen-Presenting Cells | 1 | 2003 | 965 | 0.010 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2003 | 1438 | 0.010 |
Why?
|
| Female | 4 | 2021 | 396943 | 0.010 |
Why?
|
| Humans | 5 | 2023 | 768451 | 0.010 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2003 | 1362 | 0.010 |
Why?
|
| Data Collection | 1 | 2005 | 3329 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2003 | 3816 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 20762 | 0.010 |
Why?
|
| Residence Characteristics | 1 | 2005 | 2119 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2003 | 1814 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 2005 | 3212 | 0.010 |
Why?
|
| Adult | 3 | 2019 | 223542 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 2003 | 2757 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2005 | 59680 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2005 | 81834 | 0.000 |
Why?
|
| Aged | 1 | 2005 | 171520 | 0.000 |
Why?
|
| Middle Aged | 1 | 2005 | 223418 | 0.000 |
Why?
|